

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.37276591 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.37276591 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.37276591 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.37276591 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.37276591 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.37276591 |
| 7 | response to peptidoglycan (GO:0032494) | 5.62986170 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.29817310 |
| 9 | B cell receptor signaling pathway (GO:0050853) | 5.15631777 |
| 10 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.83957944 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 4.83753151 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.76291940 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 4.71036850 |
| 14 | detection of bacterium (GO:0016045) | 4.62343578 |
| 15 | respiratory burst (GO:0045730) | 4.60387858 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 4.45628285 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.44824926 |
| 18 | detection of other organism (GO:0098543) | 4.43990276 |
| 19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.42608111 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.41725110 |
| 21 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.38853717 |
| 22 | response to host immune response (GO:0052572) | 4.38853717 |
| 23 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.34537951 |
| 24 | response to muramyl dipeptide (GO:0032495) | 4.28457804 |
| 25 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.24290883 |
| 26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.19089020 |
| 27 | granulocyte activation (GO:0036230) | 4.16866912 |
| 28 | neutrophil activation (GO:0042119) | 4.15044123 |
| 29 | B cell homeostasis (GO:0001782) | 4.14581648 |
| 30 | microglial cell activation (GO:0001774) | 4.10430193 |
| 31 | cellular extravasation (GO:0045123) | 4.09179524 |
| 32 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.07823732 |
| 33 | regulation of gamma-delta T cell activation (GO:0046643) | 4.04875332 |
| 34 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.95442831 |
| 35 | response to host (GO:0075136) | 3.95442831 |
| 36 | response to host defenses (GO:0052200) | 3.95442831 |
| 37 | negative thymic T cell selection (GO:0045060) | 3.90157427 |
| 38 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.82840323 |
| 39 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.80108572 |
| 40 | neutrophil mediated immunity (GO:0002446) | 3.78812889 |
| 41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.70270868 |
| 42 | positive regulation of antigen processing and presentation (GO:0002579) | 3.61170897 |
| 43 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.58525570 |
| 44 | negative T cell selection (GO:0043383) | 3.57066859 |
| 45 | myeloid cell activation involved in immune response (GO:0002275) | 3.56176958 |
| 46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.56024410 |
| 47 | T-helper 1 type immune response (GO:0042088) | 3.55712053 |
| 48 | superoxide anion generation (GO:0042554) | 3.55708741 |
| 49 | macrophage activation (GO:0042116) | 3.55286930 |
| 50 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.54849445 |
| 51 | positive regulation of humoral immune response (GO:0002922) | 3.53115176 |
| 52 | defense response to protozoan (GO:0042832) | 3.52766511 |
| 53 | regulation of B cell differentiation (GO:0045577) | 3.52647752 |
| 54 | B cell proliferation (GO:0042100) | 3.52547036 |
| 55 | detection of external biotic stimulus (GO:0098581) | 3.51572599 |
| 56 | T cell lineage commitment (GO:0002360) | 3.50735920 |
| 57 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.49686629 |
| 58 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.48122636 |
| 59 | negative regulation of interleukin-12 production (GO:0032695) | 3.47362698 |
| 60 | cellular response to interferon-gamma (GO:0071346) | 3.46910604 |
| 61 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.46858965 |
| 62 | positive regulation of macrophage cytokine production (GO:0060907) | 3.46465210 |
| 63 | detection of molecule of bacterial origin (GO:0032490) | 3.45384410 |
| 64 | positive regulation of mast cell activation (GO:0033005) | 3.44951431 |
| 65 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.44824911 |
| 66 | positive regulation of mast cell degranulation (GO:0043306) | 3.44824911 |
| 67 | positive thymic T cell selection (GO:0045059) | 3.44163580 |
| 68 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.42561974 |
| 69 | reactive oxygen species biosynthetic process (GO:1903409) | 3.37200534 |
| 70 | positive regulation of interferon-beta production (GO:0032728) | 3.36421778 |
| 71 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.36277104 |
| 72 | regulation of activation of Janus kinase activity (GO:0010533) | 3.33822581 |
| 73 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.33765650 |
| 74 | natural killer cell mediated immunity (GO:0002228) | 3.33765650 |
| 75 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.33400899 |
| 76 | positive regulation of B cell mediated immunity (GO:0002714) | 3.33332185 |
| 77 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.33332185 |
| 78 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.32117906 |
| 79 | cellular response to type I interferon (GO:0071357) | 3.29668927 |
| 80 | type I interferon signaling pathway (GO:0060337) | 3.29668927 |
| 81 | response to type I interferon (GO:0034340) | 3.28161623 |
| 82 | regulation of mast cell degranulation (GO:0043304) | 3.27679252 |
| 83 | negative regulation of T cell mediated immunity (GO:0002710) | 3.27321117 |
| 84 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.27066465 |
| 85 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.24898216 |
| 86 | leukocyte mediated cytotoxicity (GO:0001909) | 3.23998033 |
| 87 | response to interleukin-15 (GO:0070672) | 3.22969823 |
| 88 | T cell costimulation (GO:0031295) | 3.22806995 |
| 89 | regulation of B cell proliferation (GO:0030888) | 3.22739078 |
| 90 | leukocyte aggregation (GO:0070486) | 3.22677119 |
| 91 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.22550950 |
| 92 | negative regulation of growth of symbiont in host (GO:0044130) | 3.22105161 |
| 93 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.22105161 |
| 94 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.22105161 |
| 95 | regulation of growth of symbiont in host (GO:0044126) | 3.22105161 |
| 96 | positive regulation of B cell differentiation (GO:0045579) | 3.21735681 |
| 97 | negative regulation of B cell proliferation (GO:0030889) | 3.21249134 |
| 98 | monocyte chemotaxis (GO:0002548) | 3.21017940 |
| 99 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.20988605 |
| 100 | cellular response to interleukin-15 (GO:0071350) | 3.20867216 |
| 101 | B cell mediated immunity (GO:0019724) | 3.19242508 |
| 102 | response to protozoan (GO:0001562) | 3.17947409 |
| 103 | lymphocyte costimulation (GO:0031294) | 3.17915510 |
| 104 | positive regulation of interleukin-12 production (GO:0032735) | 3.17662417 |
| 105 | myeloid dendritic cell differentiation (GO:0043011) | 3.17266990 |
| 106 | cellular response to zinc ion (GO:0071294) | 3.15961858 |
| 107 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 3.15856747 |
| 108 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.15110464 |
| 109 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.14815633 |
| 110 | lymphocyte homeostasis (GO:0002260) | 3.12532756 |
| 111 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.12379402 |
| 112 | thymic T cell selection (GO:0045061) | 3.11470353 |
| 113 | regulation of chemokine biosynthetic process (GO:0045073) | 3.11115557 |
| 114 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.10912712 |
| 115 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.08377243 |
| 116 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.08377243 |
| 117 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.08318679 |
| 118 | positive regulation of B cell proliferation (GO:0030890) | 3.07755214 |
| 119 | negative regulation of phagocytosis (GO:0050765) | 3.06632939 |
| 120 | negative regulation of interleukin-17 production (GO:0032700) | 3.06378822 |
| 121 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.05733560 |
| 122 | positive regulation of B cell activation (GO:0050871) | 3.04104727 |
| 123 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.03634304 |
| 124 | detection of biotic stimulus (GO:0009595) | 3.03065772 |
| 125 | regulation of macrophage cytokine production (GO:0010935) | 3.02443896 |
| 126 | myeloid dendritic cell activation (GO:0001773) | 3.01282584 |
| 127 | response to interferon-gamma (GO:0034341) | 3.01042428 |
| 128 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.00571907 |
| 129 | regulation of antigen processing and presentation (GO:0002577) | 2.98872464 |
| 130 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.97307194 |
| 131 | cytokine secretion (GO:0050663) | 2.96460320 |
| 132 | myeloid leukocyte activation (GO:0002274) | 2.95156924 |
| 133 | regulation of interleukin-12 production (GO:0032655) | 2.94869678 |
| 134 | myeloid leukocyte mediated immunity (GO:0002444) | 2.92993903 |
| 135 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.90873184 |
| 136 | NIK/NF-kappaB signaling (GO:0038061) | 2.90616215 |
| 137 | neutrophil chemotaxis (GO:0030593) | 2.90570259 |
| 138 | regulation of mast cell activation (GO:0033003) | 2.90209328 |
| 139 | germinal center formation (GO:0002467) | 2.89382129 |
| 140 | positive regulation of interleukin-17 production (GO:0032740) | 2.86908556 |
| 141 | T cell migration (GO:0072678) | 2.86717771 |
| 142 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.84558598 |
| 143 | negative regulation of cell killing (GO:0031342) | 2.84558598 |
| 144 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.84259219 |
| 145 | pinocytosis (GO:0006907) | 2.82891029 |
| 146 | neutrophil migration (GO:1990266) | 2.82130622 |
| 147 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.81828825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.98947277 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.38574618 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.35320827 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.59093255 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.28360769 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.94538622 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.76484394 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.74064360 |
| 9 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.49048783 |
| 10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.47179236 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.35924476 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.34702995 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.33416008 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.85359219 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.83806304 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.81539018 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.61962456 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.60775222 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.52938774 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.50637024 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.39905473 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.37689765 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.30694718 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.27377757 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.21238262 |
| 26 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.19605857 |
| 27 | SPI1_23127762_ChIP-Seq_K562_Human | 2.08390224 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.99057890 |
| 29 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92313549 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.87009722 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85080809 |
| 32 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.81547480 |
| 33 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.80212142 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.77763526 |
| 35 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.77051591 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.76191845 |
| 37 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.74138238 |
| 38 | * MAF_26560356_Chip-Seq_TH1_Human | 1.72204873 |
| 39 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.66636684 |
| 40 | * MYB_26560356_Chip-Seq_TH2_Human | 1.66246420 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.66037647 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64759883 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63529432 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63281422 |
| 45 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62201976 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.60609326 |
| 47 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.55377417 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55176784 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.52465077 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.49378617 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48431128 |
| 52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.47705864 |
| 53 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44147964 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39931853 |
| 55 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32498735 |
| 56 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32240912 |
| 57 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30725370 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29161608 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27586325 |
| 60 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24673942 |
| 61 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.23732393 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23696987 |
| 63 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23004541 |
| 64 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21234600 |
| 65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17783811 |
| 66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17415215 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17169924 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16033866 |
| 69 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14686623 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14319867 |
| 71 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.14039879 |
| 72 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13872842 |
| 73 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11268262 |
| 74 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.10721268 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10046024 |
| 76 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09531370 |
| 77 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06544141 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05658290 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05107711 |
| 80 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04868128 |
| 81 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03578967 |
| 82 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.02956229 |
| 83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02157435 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01979953 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01595477 |
| 86 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97843349 |
| 87 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.97127524 |
| 88 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.95581334 |
| 89 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90533001 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 0.88271158 |
| 91 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87970243 |
| 92 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87454412 |
| 93 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.86073820 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85518285 |
| 95 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.85249209 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84334988 |
| 97 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.83052202 |
| 98 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.81312911 |
| 99 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81123540 |
| 100 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.79020175 |
| 101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78490738 |
| 102 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.78081360 |
| 103 | MYC_22102868_ChIP-Seq_BL_Human | 0.75817204 |
| 104 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.72978630 |
| 105 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.71089132 |
| 106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70863901 |
| 107 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.69952265 |
| 108 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.68061593 |
| 109 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.65130600 |
| 110 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64851923 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63984869 |
| 112 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.62406476 |
| 113 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.62088592 |
| 114 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61232049 |
| 115 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.60137584 |
| 116 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.59585280 |
| 117 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.58365482 |
| 118 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.57950738 |
| 119 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.57950738 |
| 120 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.57607836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.38068664 |
| 2 | MP0003436_decreased_susceptibility_to | 3.70315720 |
| 3 | MP0009785_altered_susceptibility_to | 3.64610329 |
| 4 | MP0003303_peritoneal_inflammation | 3.53279484 |
| 5 | MP0002419_abnormal_innate_immunity | 3.30736600 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.26291347 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.93371355 |
| 8 | MP0003724_increased_susceptibility_to | 2.92083671 |
| 9 | MP0004510_myositis | 2.91058934 |
| 10 | MP0005025_abnormal_response_to | 2.89741204 |
| 11 | MP0006082_CNS_inflammation | 2.77950754 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.70051953 |
| 13 | MP0001790_abnormal_immune_system | 2.64426216 |
| 14 | MP0005387_immune_system_phenotype | 2.64426216 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.63820655 |
| 16 | MP0000685_abnormal_immune_system | 2.60905628 |
| 17 | MP0005671_abnormal_response_to | 2.58471602 |
| 18 | MP0001800_abnormal_humoral_immune | 2.50715917 |
| 19 | MP0002723_abnormal_immune_serum | 2.45063588 |
| 20 | MP0009278_abnormal_bone_marrow | 2.42942420 |
| 21 | MP0005167_abnormal_blood-brain_barrier | 2.32422707 |
| 22 | MP0001819_abnormal_immune_cell | 2.22620488 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.18117958 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.16939567 |
| 25 | MP0000569_abnormal_digit_pigmentation | 2.11180972 |
| 26 | MP0001533_abnormal_skeleton_physiology | 2.05603880 |
| 27 | MP0003172_abnormal_lysosome_physiology | 2.03988929 |
| 28 | MP0001853_heart_inflammation | 1.91829725 |
| 29 | MP0000343_altered_response_to | 1.91376907 |
| 30 | MP0009840_abnormal_foam_cell | 1.90346208 |
| 31 | MP0002405_respiratory_system_inflammati | 1.86522322 |
| 32 | MP0009764_decreased_sensitivity_to | 1.82825946 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.81466974 |
| 34 | MP0004947_skin_inflammation | 1.76374211 |
| 35 | MP0005645_abnormal_hypothalamus_physiol | 1.74236573 |
| 36 | MP0003448_altered_tumor_morphology | 1.73538884 |
| 37 | MP0008469_abnormal_protein_level | 1.71433002 |
| 38 | MP0003075_altered_response_to | 1.69148411 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.66794879 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.66794879 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.64724027 |
| 42 | MP0000716_abnormal_immune_system | 1.55595002 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.54858901 |
| 44 | MP0003828_pulmonary_edema | 1.53125470 |
| 45 | MP0002006_tumorigenesis | 1.48692562 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.46306878 |
| 47 | MP0002398_abnormal_bone_marrow | 1.46261928 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.38803742 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.35722211 |
| 50 | MP0008260_abnormal_autophagy | 1.34330202 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.28687708 |
| 52 | MP0002429_abnormal_blood_cell | 1.27153067 |
| 53 | MP0005310_abnormal_salivary_gland | 1.25752018 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.24528542 |
| 55 | MP0005166_decreased_susceptibility_to | 1.23530163 |
| 56 | MP0000858_altered_metastatic_potential | 1.20329837 |
| 57 | MP0008057_abnormal_DNA_replication | 1.16992498 |
| 58 | MP0003045_fibrosis | 1.15541961 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.15488416 |
| 60 | MP0002722_abnormal_immune_system | 1.13284773 |
| 61 | MP0003690_abnormal_glial_cell | 1.09336484 |
| 62 | MP0002139_abnormal_hepatobiliary_system | 1.08496419 |
| 63 | MP0004808_abnormal_hematopoietic_stem | 1.05716783 |
| 64 | MP0009763_increased_sensitivity_to | 1.04475663 |
| 65 | MP0005076_abnormal_cell_differentiation | 1.03647262 |
| 66 | MP0001879_abnormal_lymphatic_vessel | 1.02176030 |
| 67 | MP0005164_abnormal_response_to | 1.01679094 |
| 68 | MP0003566_abnormal_cell_adhesion | 1.01183243 |
| 69 | MP0005174_abnormal_tail_pigmentation | 1.00708879 |
| 70 | MP0000604_amyloidosis | 0.99759075 |
| 71 | MP0001851_eye_inflammation | 0.99371722 |
| 72 | MP0000249_abnormal_blood_vessel | 0.96776666 |
| 73 | MP0003866_abnormal_defecation | 0.94150186 |
| 74 | MP0010307_abnormal_tumor_latency | 0.92849428 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 0.92822293 |
| 76 | MP0004381_abnormal_hair_follicle | 0.91641996 |
| 77 | MP0001873_stomach_inflammation | 0.90967469 |
| 78 | MP0002019_abnormal_tumor_incidence | 0.90282483 |
| 79 | MP0000767_abnormal_smooth_muscle | 0.89634045 |
| 80 | MP0005390_skeleton_phenotype | 0.85556188 |
| 81 | MP0000490_abnormal_crypts_of | 0.85479734 |
| 82 | MP0001348_abnormal_lacrimal_gland | 0.83420939 |
| 83 | MP0002396_abnormal_hematopoietic_system | 0.83267324 |
| 84 | MP0008874_decreased_physiological_sensi | 0.81274161 |
| 85 | MP0002332_abnormal_exercise_endurance | 0.79014563 |
| 86 | MP0003091_abnormal_cell_migration | 0.77127299 |
| 87 | MP0000465_gastrointestinal_hemorrhage | 0.76836153 |
| 88 | MP0002132_abnormal_respiratory_system | 0.76633110 |
| 89 | MP0000371_diluted_coat_color | 0.76513413 |
| 90 | MP0000015_abnormal_ear_pigmentation | 0.76055777 |
| 91 | MP0005075_abnormal_melanosome_morpholog | 0.75193422 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.74944185 |
| 93 | MP0003646_muscle_fatigue | 0.73949498 |
| 94 | MP0003806_abnormal_nucleotide_metabolis | 0.72683815 |
| 95 | MP0002933_joint_inflammation | 0.72314684 |
| 96 | MP0004883_abnormal_blood_vessel | 0.70032777 |
| 97 | MP0002693_abnormal_pancreas_physiology | 0.69666463 |
| 98 | MP0000372_irregular_coat_pigmentation | 0.65801162 |
| 99 | MP0002254_reproductive_system_inflammat | 0.65715435 |
| 100 | MP0009765_abnormal_xenobiotic_induced | 0.65558514 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.65511028 |
| 102 | MP0005670_abnormal_white_adipose | 0.64166638 |
| 103 | MP0001958_emphysema | 0.64066619 |
| 104 | MP0003763_abnormal_thymus_physiology | 0.63594509 |
| 105 | MP0001663_abnormal_digestive_system | 0.63310697 |
| 106 | MP0003705_abnormal_hypodermis_morpholog | 0.59696561 |
| 107 | MP0005451_abnormal_body_composition | 0.58073609 |
| 108 | MP0004130_abnormal_muscle_cell | 0.57424867 |
| 109 | MP0000313_abnormal_cell_death | 0.57137114 |
| 110 | MP0010368_abnormal_lymphatic_system | 0.57011650 |
| 111 | MP0003279_aneurysm | 0.56931063 |
| 112 | MP0003795_abnormal_bone_structure | 0.56707161 |
| 113 | MP0010094_abnormal_chromosome_stability | 0.56423243 |
| 114 | MP0000703_abnormal_thymus_morphology | 0.56145617 |
| 115 | MP0005623_abnormal_meninges_morphology | 0.56093064 |
| 116 | MP0003186_abnormal_redox_activity | 0.54900997 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.54242205 |
| 118 | MP0003453_abnormal_keratinocyte_physiol | 0.53937124 |
| 119 | MP0005165_increased_susceptibility_to | 0.53312216 |
| 120 | MP0002928_abnormal_bile_duct | 0.52953674 |
| 121 | MP0002163_abnormal_gland_morphology | 0.52919808 |
| 122 | MP0000609_abnormal_liver_physiology | 0.50721877 |
| 123 | MP0005621_abnormal_cell_physiology | 0.49385265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.51497051 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.90733493 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.74823639 |
| 4 | Gastrointestinal stroma tumor (HP:0100723) | 6.48978098 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.99441017 |
| 6 | Agammaglobulinemia (HP:0004432) | 5.62559947 |
| 7 | Recurrent sinusitis (HP:0011108) | 5.38910683 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.07141230 |
| 9 | IgA deficiency (HP:0002720) | 4.93421144 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.92786236 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.71069875 |
| 12 | IgM deficiency (HP:0002850) | 4.67676456 |
| 13 | Myositis (HP:0100614) | 4.52506354 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 4.49853607 |
| 15 | Lymphopenia (HP:0001888) | 4.39792452 |
| 16 | Orchitis (HP:0100796) | 4.35040519 |
| 17 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.14195042 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 4.14107000 |
| 19 | Optic neuritis (HP:0100653) | 4.11543890 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 4.11543890 |
| 21 | Recurrent bronchitis (HP:0002837) | 4.09854280 |
| 22 | Recurrent skin infections (HP:0001581) | 4.09806373 |
| 23 | Obstructive lung disease (HP:0006536) | 4.08343933 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 4.08343933 |
| 25 | Gingivitis (HP:0000230) | 4.07264666 |
| 26 | Panhypogammaglobulinemia (HP:0003139) | 3.92901218 |
| 27 | Recurrent fungal infections (HP:0002841) | 3.74499462 |
| 28 | Emphysema (HP:0002097) | 3.67513834 |
| 29 | Vasculitis (HP:0002633) | 3.66961872 |
| 30 | Stomatitis (HP:0010280) | 3.65584847 |
| 31 | Vacuolated lymphocytes (HP:0001922) | 3.55438966 |
| 32 | Restrictive lung disease (HP:0002091) | 3.51901017 |
| 33 | Increased cerebral lipofuscin (HP:0011813) | 3.49551501 |
| 34 | Abnormality of T cell physiology (HP:0011840) | 3.47374322 |
| 35 | Periodontitis (HP:0000704) | 3.34410746 |
| 36 | Hematochezia (HP:0002573) | 3.34049586 |
| 37 | Increased IgE level (HP:0003212) | 3.33128300 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 3.31309543 |
| 39 | Cellulitis (HP:0100658) | 3.28694064 |
| 40 | IgG deficiency (HP:0004315) | 3.27509284 |
| 41 | Encephalitis (HP:0002383) | 3.27181205 |
| 42 | Abnormality of glycolipid metabolism (HP:0010969) | 3.26817721 |
| 43 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.26817721 |
| 44 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.26817721 |
| 45 | Recurrent viral infections (HP:0004429) | 3.25861170 |
| 46 | Pustule (HP:0200039) | 3.22330542 |
| 47 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.20330574 |
| 48 | Thick nail (HP:0001805) | 3.12523831 |
| 49 | Glomerulonephritis (HP:0000099) | 3.09392686 |
| 50 | Basal ganglia calcification (HP:0002135) | 3.09307245 |
| 51 | Spontaneous hematomas (HP:0007420) | 3.06886636 |
| 52 | Axonal loss (HP:0003447) | 3.05391247 |
| 53 | Meningitis (HP:0001287) | 2.96755639 |
| 54 | Chronic diarrhea (HP:0002028) | 2.96093867 |
| 55 | Abnormality of T cells (HP:0002843) | 2.92691486 |
| 56 | Hemoptysis (HP:0002105) | 2.91998717 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.88665759 |
| 58 | Arterial thrombosis (HP:0004420) | 2.86267010 |
| 59 | Increased IgM level (HP:0003496) | 2.86040592 |
| 60 | Prostate neoplasm (HP:0100787) | 2.77728362 |
| 61 | Urticaria (HP:0001025) | 2.77418183 |
| 62 | Interstitial pulmonary disease (HP:0006530) | 2.68832580 |
| 63 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.68223350 |
| 64 | Recurrent cutaneous fungal infections (HP:0011370) | 2.68223350 |
| 65 | B lymphocytopenia (HP:0010976) | 2.66798127 |
| 66 | Viral hepatitis (HP:0006562) | 2.66794642 |
| 67 | Verrucae (HP:0200043) | 2.64394728 |
| 68 | Papilloma (HP:0012740) | 2.64394728 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.63810965 |
| 70 | Keratoconjunctivitis sicca (HP:0001097) | 2.61181460 |
| 71 | Leukocytosis (HP:0001974) | 2.58624379 |
| 72 | Purpura (HP:0000979) | 2.57600814 |
| 73 | Osteomyelitis (HP:0002754) | 2.57114372 |
| 74 | Disinhibition (HP:0000734) | 2.54722032 |
| 75 | Skin rash (HP:0000988) | 2.54358653 |
| 76 | Nephritis (HP:0000123) | 2.53903045 |
| 77 | Leukopenia (HP:0001882) | 2.50843427 |
| 78 | Hypertensive crisis (HP:0100735) | 2.50627690 |
| 79 | Abnormality of B cell number (HP:0010975) | 2.50587792 |
| 80 | Recurrent pneumonia (HP:0006532) | 2.49684395 |
| 81 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.49201442 |
| 82 | Tetraparesis (HP:0002273) | 2.48510399 |
| 83 | Lymphoma (HP:0002665) | 2.47864836 |
| 84 | Sepsis (HP:0100806) | 2.46160571 |
| 85 | Prolonged bleeding time (HP:0003010) | 2.44840591 |
| 86 | Dysostosis multiplex (HP:0000943) | 2.44821028 |
| 87 | Joint hemorrhage (HP:0005261) | 2.44671444 |
| 88 | Chest pain (HP:0100749) | 2.44350109 |
| 89 | Abnormality of the prostate (HP:0008775) | 2.43001395 |
| 90 | Gingival bleeding (HP:0000225) | 2.41519167 |
| 91 | Chronic otitis media (HP:0000389) | 2.41337736 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.39131449 |
| 93 | Colitis (HP:0002583) | 2.38426213 |
| 94 | Keratoconjunctivitis (HP:0001096) | 2.38153860 |
| 95 | Basal cell carcinoma (HP:0002671) | 2.33097294 |
| 96 | Xerostomia (HP:0000217) | 2.31715344 |
| 97 | Premature loss of primary teeth (HP:0006323) | 2.27798418 |
| 98 | Myocardial infarction (HP:0001658) | 2.27604367 |
| 99 | Porencephaly (HP:0002132) | 2.23918623 |
| 100 | Esophageal varix (HP:0002040) | 2.23630576 |
| 101 | Granulocytopenia (HP:0001913) | 2.22327065 |
| 102 | Eosinophilia (HP:0001880) | 2.19288559 |
| 103 | Loss of speech (HP:0002371) | 2.19106685 |
| 104 | Hepatosplenomegaly (HP:0001433) | 2.18335053 |
| 105 | Recurrent lower respiratory tract infections (HP:0002783) | 2.17691581 |
| 106 | Petechiae (HP:0000967) | 2.16065532 |
| 107 | Abnormality of the pleura (HP:0002103) | 2.15779983 |
| 108 | Bronchitis (HP:0012387) | 2.14765874 |
| 109 | Anorexia (HP:0002039) | 2.13392926 |
| 110 | Osteolytic defects of the hand bones (HP:0009699) | 2.12954889 |
| 111 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.12954889 |
| 112 | Inflammation of the large intestine (HP:0002037) | 2.12447639 |
| 113 | Abnormality of the peritoneum (HP:0002585) | 2.12253095 |
| 114 | Amyloidosis (HP:0011034) | 2.11053468 |
| 115 | Abnormality of the nasal mucosa (HP:0000433) | 2.07909217 |
| 116 | Abnormality of the pericardium (HP:0001697) | 2.07011307 |
| 117 | Hepatitis (HP:0012115) | 2.05950146 |
| 118 | Recurrent otitis media (HP:0000403) | 2.03200430 |
| 119 | Bone pain (HP:0002653) | 2.02474182 |
| 120 | Acrocyanosis (HP:0001063) | 2.01714510 |
| 121 | Abnormality of T cell number (HP:0011839) | 2.01274435 |
| 122 | Dry hair (HP:0011359) | 2.00588197 |
| 123 | Agnosia (HP:0010524) | 2.00403551 |
| 124 | Epistaxis (HP:0000421) | 2.00138766 |
| 125 | Skin ulcer (HP:0200042) | 1.99960697 |
| 126 | Peritonitis (HP:0002586) | 1.97826664 |
| 127 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.97392050 |
| 128 | Gangrene (HP:0100758) | 1.96597892 |
| 129 | Gastrointestinal inflammation (HP:0004386) | 1.96103450 |
| 130 | Poor head control (HP:0002421) | 1.94858439 |
| 131 | Squamous cell carcinoma (HP:0002860) | 1.94041049 |
| 132 | Abnormality of complement system (HP:0005339) | 1.93796492 |
| 133 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.93327550 |
| 134 | Mucopolysacchariduria (HP:0008155) | 1.93327550 |
| 135 | Pulmonary fibrosis (HP:0002206) | 1.93039061 |
| 136 | Pulmonary embolism (HP:0002204) | 1.89257563 |
| 137 | T lymphocytopenia (HP:0005403) | 1.89062652 |
| 138 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.85886675 |
| 139 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.85886675 |
| 140 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.85886675 |
| 141 | Progressive visual loss (HP:0000529) | 1.84808823 |
| 142 | Arthralgia (HP:0002829) | 1.83304722 |
| 143 | Pathologic fracture (HP:0002756) | 1.83169296 |
| 144 | Nasal polyposis (HP:0100582) | 1.82893321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.63120949 |
| 2 | MAP3K14 | 3.93966875 |
| 3 | PRPF4B | 3.48051030 |
| 4 | TBK1 | 3.42982503 |
| 5 | IRAK4 | 3.42915231 |
| 6 | IRAK3 | 3.42514691 |
| 7 | TYK2 | 3.42370642 |
| 8 | BLK | 3.40263563 |
| 9 | MAP4K1 | 2.85679367 |
| 10 | TGFBR2 | 2.52904105 |
| 11 | IKBKE | 2.45614376 |
| 12 | JAK3 | 2.36054485 |
| 13 | ERN1 | 2.24940301 |
| 14 | IKBKB | 2.23019638 |
| 15 | TIE1 | 2.21417503 |
| 16 | SMG1 | 2.07458770 |
| 17 | JAK1 | 2.03540009 |
| 18 | CSK | 1.81015937 |
| 19 | KIT | 1.74013614 |
| 20 | MAP3K13 | 1.68664680 |
| 21 | KDR | 1.61153150 |
| 22 | HCK | 1.50213544 |
| 23 | TXK | 1.49913559 |
| 24 | MARK3 | 1.46969703 |
| 25 | PBK | 1.42919762 |
| 26 | STK10 | 1.42795877 |
| 27 | FES | 1.42400955 |
| 28 | SYK | 1.39953138 |
| 29 | ZAP70 | 1.39722243 |
| 30 | CSF1R | 1.39325798 |
| 31 | VRK1 | 1.39153814 |
| 32 | EPHB1 | 1.31346310 |
| 33 | BTK | 1.30218520 |
| 34 | TNK2 | 1.29729606 |
| 35 | CHUK | 1.26539089 |
| 36 | TTN | 1.26516215 |
| 37 | TLK1 | 1.25634472 |
| 38 | MAP2K3 | 1.25444911 |
| 39 | JAK2 | 1.23584935 |
| 40 | FGR | 1.22767108 |
| 41 | GRK7 | 1.22758171 |
| 42 | CDC42BPA | 1.16606383 |
| 43 | CDK12 | 1.15572176 |
| 44 | LYN | 1.13078287 |
| 45 | SIK2 | 1.11000780 |
| 46 | PIM2 | 1.09090771 |
| 47 | PIM1 | 1.07898436 |
| 48 | CLK1 | 1.07017156 |
| 49 | RIPK1 | 1.05892450 |
| 50 | TAOK2 | 1.04468464 |
| 51 | TEC | 1.04397242 |
| 52 | LCK | 1.02041498 |
| 53 | MAP3K5 | 0.95740498 |
| 54 | STK4 | 0.95510879 |
| 55 | BMX | 0.94717841 |
| 56 | EIF2AK2 | 0.94597713 |
| 57 | CAMK1D | 0.93098037 |
| 58 | MATK | 0.89791684 |
| 59 | EEF2K | 0.89302716 |
| 60 | NEK9 | 0.88395030 |
| 61 | TAOK3 | 0.87170985 |
| 62 | MAPK11 | 0.85249974 |
| 63 | MAP3K10 | 0.85183455 |
| 64 | TRPM7 | 0.82785888 |
| 65 | PASK | 0.79584143 |
| 66 | BMPR2 | 0.77755667 |
| 67 | PTK6 | 0.77697790 |
| 68 | CDK19 | 0.75092576 |
| 69 | RPS6KA4 | 0.74496937 |
| 70 | RPS6KA5 | 0.73689170 |
| 71 | MAPK7 | 0.73677038 |
| 72 | EIF2AK3 | 0.73219086 |
| 73 | MAP3K11 | 0.72064460 |
| 74 | TESK2 | 0.67451704 |
| 75 | TAF1 | 0.66067822 |
| 76 | BCKDK | 0.65459563 |
| 77 | ZAK | 0.65137908 |
| 78 | EGFR | 0.62950225 |
| 79 | TRIB3 | 0.62315091 |
| 80 | PRKCD | 0.61867997 |
| 81 | CDK4 | 0.61484810 |
| 82 | ABL1 | 0.60162122 |
| 83 | PAK4 | 0.59845734 |
| 84 | ABL2 | 0.58475209 |
| 85 | PDK1 | 0.56621418 |
| 86 | PDPK1 | 0.56247083 |
| 87 | DDR2 | 0.55926891 |
| 88 | MAP3K3 | 0.55401649 |
| 89 | SIK3 | 0.54839864 |
| 90 | MOS | 0.54369524 |
| 91 | PTK2B | 0.54191117 |
| 92 | YES1 | 0.53928538 |
| 93 | PRKCH | 0.53319983 |
| 94 | RPS6KA6 | 0.53021743 |
| 95 | CCNB1 | 0.52411855 |
| 96 | MELK | 0.52163931 |
| 97 | HIPK2 | 0.50949792 |
| 98 | MAP3K8 | 0.50202057 |
| 99 | KSR2 | 0.48741055 |
| 100 | GRK6 | 0.47056838 |
| 101 | ITK | 0.46743118 |
| 102 | PDK2 | 0.45471869 |
| 103 | SIK1 | 0.44608861 |
| 104 | STK3 | 0.44543279 |
| 105 | CAMK1G | 0.44368859 |
| 106 | MAPK12 | 0.44045498 |
| 107 | RPS6KL1 | 0.43837516 |
| 108 | RPS6KC1 | 0.43837516 |
| 109 | IRAK2 | 0.43448369 |
| 110 | MAPKAPK2 | 0.41928184 |
| 111 | TAOK1 | 0.41725129 |
| 112 | PRKG2 | 0.41193645 |
| 113 | ALK | 0.39340125 |
| 114 | PIK3CG | 0.34611011 |
| 115 | LRRK2 | 0.33580739 |
| 116 | MAP3K12 | 0.33355534 |
| 117 | CDK9 | 0.33183679 |
| 118 | STK24 | 0.33022093 |
| 119 | IRAK1 | 0.32361782 |
| 120 | MST1R | 0.31772980 |
| 121 | DAPK3 | 0.31642519 |
| 122 | PRKCQ | 0.30385206 |
| 123 | FGFR4 | 0.30224328 |
| 124 | NME1 | 0.30168171 |
| 125 | RPS6KA2 | 0.29738440 |
| 126 | FGFR3 | 0.29443278 |
| 127 | MAPK4 | 0.29217876 |
| 128 | MAP3K1 | 0.28731070 |
| 129 | MAP3K9 | 0.26184132 |
| 130 | DMPK | 0.25393878 |
| 131 | FYN | 0.25285684 |
| 132 | NME2 | 0.24837485 |
| 133 | NEK2 | 0.24211167 |
| 134 | ARAF | 0.23500782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.43257778 |
| 2 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 3.21267348 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.13223648 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.88639130 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.64992651 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.62917293 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.55832353 |
| 8 | Legionellosis_Homo sapiens_hsa05134 | 2.52606458 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.51483895 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.48004283 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.32143790 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 2.25251636 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.17929568 |
| 14 | Malaria_Homo sapiens_hsa05144 | 2.14582855 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.13404015 |
| 16 | Measles_Homo sapiens_hsa05162 | 2.11776071 |
| 17 | Influenza A_Homo sapiens_hsa05164 | 1.97405584 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.95903631 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94891038 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.91266962 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.91117121 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.87264533 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.81282838 |
| 24 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.78662590 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.76808305 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.68410075 |
| 27 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.65046329 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.63060657 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.61046552 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.60321246 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.57277067 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.50259552 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.50156084 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.48393074 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.48357494 |
| 36 | Alcoholism_Homo sapiens_hsa05034 | 1.47807678 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.42378530 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.40158328 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34106779 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.33475892 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.31154869 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.27066802 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25614493 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.23890914 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20207095 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.18629617 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14244695 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13269529 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 1.03233691 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.01840762 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96187956 |
| 52 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.93169787 |
| 53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90868355 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.90015780 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84340460 |
| 56 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82404182 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77904820 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76115141 |
| 59 | Platelet activation_Homo sapiens_hsa04611 | 0.75863416 |
| 60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.74520874 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68885104 |
| 62 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.68787909 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.68425791 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67841232 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66277535 |
| 66 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64487258 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64236327 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63227622 |
| 69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62666710 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62664614 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.61305912 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57292213 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53050985 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52131240 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50021910 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.48211516 |
| 77 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44339107 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43641659 |
| 79 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43209423 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.42495563 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42000206 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41588608 |
| 83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34920878 |
| 84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34547238 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34427325 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32753516 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.30815425 |
| 88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29986788 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28368336 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28209585 |
| 91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.27880647 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26375147 |
| 93 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26327396 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.23403836 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.23030864 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.22433004 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.22379402 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.21192021 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.21019126 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.20925638 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20698327 |
| 102 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.20468604 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20139321 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.19235502 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18480633 |
| 106 | Focal adhesion_Homo sapiens_hsa04510 | 0.17231578 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.16182550 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.15492256 |
| 109 | Adherens junction_Homo sapiens_hsa04520 | 0.15121231 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.14625130 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.13901798 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.12852335 |
| 113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.11799857 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.10268751 |
| 115 | DNA replication_Homo sapiens_hsa03030 | 0.07995125 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.06168505 |
| 117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.05218800 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.02866167 |

